We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+16.92%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$856M
AUM Growth
-$46.4M
Cap. Flow
-$173M
Cap. Flow %
-20.16%
Top 10 Hldgs %
41.76%
Holding
72
New
17
Increased
18
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$40.9M
2
NVS icon
Novartis
NVS
+$35.1M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$25.7M
4
VTRS icon
Viatris
VTRS
+$24.6M
5
EW icon
Edwards Lifesciences
EW
+$18.8M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$53.6M
2
CI icon
Cigna
CI
+$28.3M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$26M
4
AET
Aetna Inc
AET
+$22.6M
5
BIIB icon
Biogen
BIIB
+$20.7M

Sector Composition

Rank Sector Weight
1 Healthcare 94.17%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDRM
26
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$13M 1.52%
489,267
+48,468
+11% +$1.2M
COLL icon
27
Collegium Pharmaceutical
COLL
$1.14B
$12.9M 1.5%
1,279,247
-825,509
-39% -$12.3M
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
$12.7M 1.49%
345,582
-780,219
-69% -$19.7M
ARAY icon
29
Accuray
ARAY
$28.4M
$11.8M 1.38%
2,482,621
-589,915
-19% -$3.07M
IART icon
30
Integra LifeSciences
IART
$1.54B
$8.53M 1%
202,499
+64,099
+46% +$2.74M
ENDP
31
DELISTED
Endo International plc
ENDP
$8.15M 0.95%
+730,150
New +$9.07M
PRTA icon
32
Prothena Corp
PRTA
$458M
$7.87M 0.92%
141,046
+17,400
+14% +$914K
EVHC
33
DELISTED
Envision Healthcare Holdings Inc
EVHC
$7.67M 0.9%
125,050
+10
+0% +$670
NVO
34
Novo Nordisk
NVO
$216B
$7.46M 0.87%
434,960
-37,800
-8% -$658K
ADXS
35
DELISTED
Advaxis Inc
ADXS
$6.86M 0.8%
55,985
+9,980
+22% +$1.3M
MNTA
36
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6.14M 0.72%
460,300
+80,800
+21% +$1.27M
KITE
37
DELISTED
Kite Pharma, Inc.
KITE
$4.99M 0.58%
63,520
-308,703
-83% -$19.1M
MASI
38
DELISTED
Masimo
MASI
$4.97M 0.58%
+53,300
New +$4.39M
RARX
39
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.8M 0.56%
225,340
-27,600
-11% -$528K
DBVT
40
DBV Technologies
DBVT
$807M
$4.7M 0.55%
13,350
+9,510
+248% +$3.34M
LOXO
41
DELISTED
Loxo Oncology, Inc
LOXO
$3.8M 0.44%
+90,390
New +$3.72M
MOH icon
42
Molina Healthcare
MOH
$10.3B
$3.72M 0.43%
81,575
-55,270
-40% -$2.89M
PTCT icon
43
PTC Therapeutics
PTCT
$6.37B
$3.46M 0.4%
351,135
+228,000
+185% +$2.76M
XLRN
44
DELISTED
Acceleron Pharma
XLRN
$3.35M 0.39%
126,400
-218,825
-63% -$5.77M
BIIB icon
45
Biogen
BIIB
$29.9B
$3.2M 0.37%
11,711
-73,130
-86% -$20.7M
AGIO icon
46
Agios Pharmaceuticals
AGIO
$2.16B
$2.99M 0.35%
51,200
-3,700
-7% -$177K
XENT
47
DELISTED
Intersect ENT, Inc
XENT
$2.46M 0.29%
143,240
-391,697
-73% -$5.49M
LJPC
48
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.35M 0.27%
+78,700
New +$2.01M
INCY icon
49
Incyte
INCY
$23.5B
$2.29M 0.27%
17,145
-17,229
-50% -$2.19M
REGN icon
50
Regeneron Pharmaceuticals
REGN
$68.8B
$2.21M 0.26%
+5,695
New +$2.11M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Sectoral Asset Management held 72 positions worth $856M, down 5.1% from $903M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management withdrew a net $173M in Q1 2017, closing 7 positions and reducing 27 holdings. Its most notable exit was Eli Lilly, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 90% a quarter earlier, followed by Financials.

Against the trend, Sectoral Asset Management opened a new position in Johnson & Johnson worth $42.6M.

  • Sectoral Asset Management's largest Q1 2017 buy was Johnson & Johnson: 342,350 shares worth $42.6M.
  • Sectoral Asset Management added most to K2M Group Holdings, Inc in Q1 2017, an estimated $14M increase.
  • Sectoral Asset Management's biggest Q1 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $26M.
  • Sectoral Asset Management fully exited Eli Lilly in Q1 2017, selling an estimated $53.6M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $856M portfolio in Q1 2017.
  • Sectoral Asset Management opened 17 new positions and closed 7 in Q1 2017.
  • Sectoral Asset Management's portfolio value fell 5.1% quarter-over-quarter to $856M.

Based on Sectoral Asset Management's 13F filing for Q1 2017, filed 15 May 2017.